Cancer Drug Development

The Princess Margaret, with its world-leading research facility, the Ontario Cancer Institute (OCI), is especially well-suited to excel and succeed in developing new drugs for cancer patients.  That is because the facility is:
  • focused 100 percent on cancer research and treatment, including all types of cancer
  • a world leader in basic science research, and
  • located in a large, multicultural city which provides a large patient base for clinical studies
This article provides background information on the steps involved in developing a new cancer drug and bringing it to market, followed by descriptions of specific drug development initiatives going on at The Princess Margaret.

Dr. Lillian Siu, Co-Director of the Robert and Maggie Bras Drug Development Program, speaks about some of the successes and her aspirations.
Dr. Aaron Schimmer, a Scientist with OCI’s Division of Cancer Genomics and Proteomics and one of the Report on Business Top 40 Under 40 talks about some promising drug developments at The Princess Margaret
You have an old version of Adobe's Flash Player. Get the latest Flash player.